AbbVie traded at $153.33 this Tuesday July 5th, decreasing $0.47 or 0.31 percent since the previous trading session. Looking back, over the last four weeks, AbbVie lost 4.64 percent. Over the last 12 months, its price rose by 32.49 percent. Looking ahead, we forecast AbbVie to be priced at 149.63 by the end of this quarter and at 137.79 in one year, according to Trading Economics global macro models projections and analysts expectations.

Stock Price
153.33
Daily Change
-0.31%
Yearly
32.49%

Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Peers Price Day Year
Eisai 5,825.00 0 0% -44.52%
AbbVie 153.33 -0.47 -0.31% 32.49%
Abbott 109.17 -1.05 -0.95% -8.12%
ALKERMES 31.03 0.50 1.64% 21.40%
Amgen 245.38 -0.17 -0.07% 0.71%
AstraZeneca 10,800.00 -8.00 -0.07% 23.84%
Astrazeneca 64.82 -1.13 -1.71% 8.21%
Biogen 212.19 1.56 0.74% -38.48%
BioMarin Pharmaceutical 85.19 0.21 0.25% 0.73%
Bristol-Myers Squibb 75.60 -1.24 -1.61% 13.43%
ChemoCentryx 25.68 -1.09 -4.05% 82.74%
Coherus Biosciences 8.24 0.41 5.24% -39.55%
Endo International 0.54 -0.03 -5.81% -87.82%
Gilead Sciences 62.12 -0.24 -0.38% -9.19%
GlaxoSmithKline 1,786.60 -16.00 -0.89% 24.57%
Horizon Pharma 82.68 1.84 2.28% -13.68%
Intercept Pharmaceuticals 14.87 0.74 5.24% -21.90%
Infinity Pharmaceuticals 0.61 0.02 3.66% -78.54%
Jazz Pharmaceuticals 156.99 -1.59 -1.00% -14.18%
J&J 177.25 -2.27 -1.26% 5.52%
Eli Lilly 324.34 -0.37 -0.11% 37.77%
Medtronic 90.35 -1.03 -1.13% -28.84%
Merck & Co 92.24 -0.18 -0.19% 18.09%
Neurocrine Biosciences 98.07 -1.18 -1.19% 0.64%
Novartis 80.91 -0.74 -0.91% -4.31%
Pacira 57.66 -0.19 -0.33% 0.03%
Pfizer 51.29 -1.01 -1.93% 30.54%
Perrigo 40.44 -0.58 -1.41% -13.77%
Ultragenyx Pharmaceutical 64.18 1.53 2.44% -29.80%
Regeneron Pharmaceuticals 591.32 -4.08 -0.69% 1.56%
Roche Holding 319.00 -3.60 -1.12% -9.76%
Revance Therapeutics 14.52 0.19 1.33% -54.70%
Sanofi 97.12 -1.22 -1.24% 11.93%
Teva Pharmaceutical Industries 7.67 -0.22 -2.79% -20.19%
UCB 82.60 -0.04 -0.05% -6.92%
United Therapeutics 235.54 -2.46 -1.03% 27.13%
Vertex Pharmaceuticals 288.29 0.97 0.34% 44.11%
Zoetis 173.42 -0.79 -0.45% -10.62%

Indexes Price Day Year
US500 3819 -6.39 -0.17% -12.08%

AbbVie
AbbVie Inc. (AbbVie) is a research-based biopharmaceutical company. The Company is engaged in research and development, manufacturing, commercialization and sale of medicines and therapies. AbbVie offers its products in various therapeutic categories, including Immunology products, which include Humira, Skyrizi and Rinvoq; Oncology products consists of Imbruvica and Venclexta; Aesthetics products include Botox Cosmetic, Juvederm Collection and other aesthetics; Neuroscience products, such as Botox Therapeutic, Vraylar, Duopa and Duodopa, and Ubrelvy; Eye care products consists of Lumigan, Alphagan and Restasis ; Women's health products incudes Lo Loestrin, Orilissa and other women's health; and Other key products, which includes Mavyret, Creon, Lupron, Linzess and Synthroid. The Company's products are sold worldwide directly to wholesalers, distributors, government agencies, health care facilities and independent retailers from AbbVie-owned distribution centers and public warehouses.